A Bull and a Bear Walk Into Renk: Wellington and AQR Square Off Ahead of Q1 Numbers

Renk Group's Q1 2026 report on May 6 could decide a battle between bullish Wellington Management and bearish AQR Capital, as record orders clash with cash flow woes and an Israel export embargo.

The stage is set for a pivotal moment at Renk Group. On May 6, the Augsburg-based drive systems specialist will release its first-quarter 2026 results, and the numbers could tip the scales in an increasingly public tug-of-war between two heavyweight investors. Wellington Management has built a 5.09 percent stake, signalling conviction, while AQR Capital Management holds a net short position of 2.38 percent, betting against the stock. Marshall Wace adds another 0.58 percent to the bearish camp.

The divergence in sentiment is not hard to explain. Renk’s order book is booming, but its cash flow is not keeping pace — and an export embargo has added a geopolitical twist that complicates the outlook.

A Record Quarter Hiding in Plain Sight

The headline figures for Q1 are expected to look underwhelming. Analysts forecast revenue of around €280 million, well below the earlier consensus of €304 million. Adjusted EBIT is seen at roughly €40 million, a slight dip from the prior-year period. But the weakness is largely a matter of timing. Renk shifted approximately €200 million in revenues from 2025 into the first half of 2026. Whether those sales have now been booked as planned will be the central question when the quarterly report lands.

On the order intake side, the picture is far brighter. During a pre-close call on April 22, management flagged a record quarter. Estimates point to around €585 million in new business, smashing market expectations of €500 million. The company has already secured more than 90 percent of its full-year revenue target of over €1.5 billion.

The €100 Million Question: Israel and the US Pivot

The elephant in the room remains Germany’s export embargo on defence goods to Israel. Renk supplies transmission systems for the Merkava and Namer armoured vehicles, putting an estimated €80 million to €100 million in 2026 revenue at risk. The company’s response has been decisive: it is shifting the affected production line to its facility in Muskegon, Michigan. Future deliveries will run through the US Foreign Military Sales programme, bypassing German export controls entirely.

The Michigan plant is set to receive $150 million in investment by 2030, with up to 270 new jobs created. Separately, Renk is ploughing half a billion euros into new facilities in Poland. The strategic pivot is designed to insulate the business from future regulatory shocks, but it also underscores the fragility of relying on any single jurisdiction for defence exports.

Cash Flow: The Real Battleground

For all the noise around orders and embargoes, the core debate among investors is about cash conversion. In 2024, Renk generated free cash flow of €67 million, translating into a cash conversion rate of just 47.2 percent — well below its self-imposed target of over 80 percent. The €200 million in deferred revenues from last year were supposed to help close that gap. If the Q1 report shows those funds have materialised as operating cash flow, the bulls will have ammunition. If not, the bears will feel vindicated.

The stock is trading at €53.93, roughly 39 percent below its 52-week high of €88.73. The relative strength index sits at 86.6, a technically overbought reading that suggests expectations are running high ahead of the release.

Insider Buying and Analyst Divergence

A signal of confidence came from within the C-suite. Chief Financial Officer Anja Manz-Siebje purchased shares on the open market following the recent pullback. Management has reiterated its full-year guidance for adjusted EBIT in the range of €255 million to €285 million, with a margin in the upper half of the target band.

Analyst opinions remain split. Jefferies holds a price target of €78, JPMorgan €75, and Deutsche Bank €73 — all implying significant upside from current levels. Goldman Sachs is more cautious at €70 with a neutral stance, while mwb research sticks with “Hold” at €53, warning that consensus revenue estimates for Q1 may need to be trimmed.

What Happens Next

On May 7, the day after the quarterly release, Renk’s management will meet with investors in Frankfurt. Export risks and the US production shift are expected to dominate the conversation. But the immediate catalyst is the Q1 report itself. The market will be looking for one number above all: whether the €200 million in deferred revenue has finally turned into cash.

The answer will determine which side of the trade — Wellington or AQR — has the better read on Renk’s trajectory.